Business Wire (October 25, 2006)
Permanent Link:
http://vlex.com/vid/oxigene-third-2006-operational-financial-56746420
Id. vLex: VLEX-56746420
Acceda a este documento
y pruebe vLex GRATIS durante 3 días
Business
Business, general
Clinical trials
Pharmaceutical industry
Product development
Company earnings/profit
Company sales and earnings
OXiGENE Reports Third-Quarter 2006 Operational and Financial Results.
OXiGENE:
* Outlines goals and priorities going forward * Describes newly observed safety characteristics and potentially promising new combination alternatives for its compounds * Sets strategic pathway for its clinical development WALTHAM, Mass. -- OXiGENE, Inc. (NASDA...Try vLex for FREE for 3 days
Access legal information from United States including:
Try vLex without any commitment for 3 days and see why you need it.
3
days of Free Access
If you are already a vLex customer, Access Here